Cited by 102Computational Drug Discovery Methodsvaccines and immunoinformatics approachesMonoclonal and Polyclonal Antibodies Research

DLAB-deep learning methods for structure-based virtual screening of antibodies

Open access
Schneider, Constantin, Buchanan, Andrew, Taddese, Bruck, Deane, Charlotte M·2022·Bioinformatics

Published version of a preprint

Abstract

MOTIVATION: Antibodies are one of the most important classes of pharmaceuticals, with over 80 approved molecules currently in use against a wide variety of diseases. The drug discovery process for antibody therapeutic candidates however is time- and cost-intensive and heavily reliant on in vivo and in vitro high throughput screens. Here, we introduce a framework for structure-based deep learning for antibodies (DLAB) which can virtually screen putative binding antibodies against antigen targets of interest. DLAB is built to be able to predict antibody-antigen binding for antigens with no known antibody binders. RESULTS: We demonstrate that DLAB can be used both to improve antibody-antigen docking and structure-based virtual screening of antibody drug candidates. DLAB enables improved pose ranking for antibody docking experiments as well as selection of antibody-antigen pairings for which accurate poses are generated and correctly ranked. We also show that DLAB can identify binding antibodies against specific antigens in a case study. Our results demonstrate the promise of deep learning methods for structure-based virtual screening of antibodies. AVAILABILITY AND IMPLEMENTATION: The DLAB source code and pre-trained models are available at https://github.com/oxpig/dlab-public. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/bioinformatics/btab660

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DLAB localizes the interface of an antibody and antigen and uses a 3D convolution-based neural network to generate binding scores.

    “For example, DLAB [52] localizes the interface of an antibody and antigen and uses a 3D convolution-based neural network to generate binding scores.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schneider, C., Buchanan, A., Taddese, B., & Deane, C. M.
Affiliations
  • University of Oxford (GB)
  • AstraZeneca (United Kingdom) (GB)
Corresponding author
Deane, Charlotte M
Venue
Bioinformatics
Published
2021-09-21
Volume
38
Issue
2
Pages
377-383
ISSN
  • 1367-4803 (ISSN-L)
  • 1367-4811
OpenAlex
W3197596721
Cited by
102
References
41
Citations by year
2026: 9 · 2025: 24 · 2024: 22 · 2023: 26 · 2022: 18 · 2021: 3
FWCI
9.06
Type
journal article
Language
en
Open access
Locations
  • Bioinformatics (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Engineering and Physical Sciences Research Council
  • Medical Research Council (EP/L016044/1)
  • AstraZeneca
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
Keywords
structure-based virtual screening, antibody-antigen docking, deep learning, pose ranking
MeSH terms
Deep Learning, Antibodies, Antigens, Software

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review